IDEXX Laboratories Inc. 8-K Filing Report - Key Financial Insights

Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Name: IDEXX Laboratories Inc.
- CIK: 0000874716
- Address: One IDEXX Drive, Westbrook, ME 04092
- Stock Symbol: IDXX
- Exchange: NASDAQ
- Filing Information:
- Filing Type: 8-K
- Filing Date: October 6, 2025
- SEC File Number: 000-19271
- IRS Number: 01-0393723
- Financial Metrics:
- Common Stock:
- Par Value: $0.10 per share
- Measurement Units:
- Currency: USD (US Dollars)
- Shares: Denoted as shares
- Share Value: USD per Share (USDPShares)
- Context:
- Reporting Period: As of October 6, 2025
- Context ID: AsOf2025-10-06
Insights:
- The report indicates that IDEXX Laboratories Inc. is actively filing relevant updates with the SEC, as evidenced by the 8-K filing, which is used to report unscheduled material events or corporate changes.
- The presence of the stock symbol and its listing on NASDAQ suggests that IDEXX is a publicly traded company, which may attract investor interest and market analysis.
- The common stock's par value of $0.10 indicates a low nominal value per share, which can be typical for companies that may have significant retained earnings and a higher market price per share.
Overall, this section of the financial report provides a snapshot of IDEXX Laboratories Inc.'s corporate identity, recent regulatory compliance actions, and basic stock information. Further analysis would require additional details about the content of the 8-K filing to understand the material event or information being reported.